Steven Larson

Biography

Dr. Larson is a co-founder of Elucida Oncology and co-inventor of the company's core intellectual property. Dr. Larson is a physician-scientist at Memorial Sloan Kettering Cancer Center. Dr. Larson is dual-boarded in nuclear medicine and internal medicine, with primary expertise in molecular imaging, targeted radio diagnosis and therapy using small molecules and monoclonal antibodies. Dr. Larson has developed PET programs at a number of major institutions across the U.S. and has served as Chair of many applicable committees, including those at FDA, NIH, NCI, the National Research Council and RSNA. Dr. Larson has over 500 peer-reviewed publications to his name and has received numerous awards for excellence in nuclear medicine. He is a member of the national Academy of Medicine, USA. 

Research Interest

Elucida Oncology, Inc.™ is a biotechnology company focused on clinical research, development and subsequent commercialization of life-changing products based on the Target or Clear™ technology of our novel, ultra-small nanoparticle delivery platform